Correlation Between Aridis Pharmaceuticals and Champions Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Champions Oncology, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Champions Oncology.

Diversification Opportunities for Aridis Pharmaceuticals and Champions Oncology

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Aridis and Champions is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Champions Oncology go up and down completely randomly.

Pair Corralation between Aridis Pharmaceuticals and Champions Oncology

If you would invest  27.00  in Aridis Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of  0.00  from holding Aridis Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

Aridis Pharmaceuticals  vs.  Champions Oncology

 Performance 
       Timeline  
Aridis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Champions Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Champions Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Champions Oncology is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Aridis Pharmaceuticals and Champions Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aridis Pharmaceuticals and Champions Oncology

The main advantage of trading using opposite Aridis Pharmaceuticals and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.
The idea behind Aridis Pharmaceuticals and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance